Common use

Dolutegravir is a modern, highly effective antiretroviral medication used in the treatment of HIV-1 infection in adults and children who meet age and weight requirements. If you want to buy Dolutegravir online, this potent integrase inhibitor — available as an affordable Tivicay generic — represents one of the most important advances in HIV treatment in recent years. Dolutegravir belongs to the class of integrase strand transfer inhibitors (INSTIs), which work by blocking the HIV integrase enzyme that the virus needs to insert its genetic material into human CD4 cells. By preventing this critical step in the viral replication cycle, dolutegravir effectively reduces viral load in the bloodstream and allows the immune system to recover and strengthen over time. This AIDS medication is typically used as part of a comprehensive combination antiretroviral therapy (cART) regimen alongside other HIV drugs. Due to its high genetic barrier to resistance, once-daily dosing convenience, excellent tolerability profile, and potent viral suppression, dolutegravir has become a preferred first-line INSTI recommended by major HIV treatment guidelines worldwide, including those from the WHO and DHHS.

Dosage and direction

The standard adult dose of dolutegravir is 50 mg once daily, taken either alone or in combination with other antiretroviral medications, depending on your treatment history and resistance profile. In certain clinical situations — such as when co-administered with potent enzyme-inducing drugs like rifampin or efavirenz, or in patients with known INSTI resistance — the dosage may be increased to 50 mg twice daily to maintain adequate drug levels. Dolutegravir can be taken with or without food, though taking it with a meal may improve absorption and reduce gastrointestinal side effects. Swallow the tablet whole with water. Always follow your healthcare provider's instructions precisely regarding dose, timing, and combination therapy. Consistent daily adherence to your HIV treatment regimen is absolutely critical to maintaining viral suppression and preventing the development of drug-resistant virus strains.

Precautions

Before you buy dolutegravir or begin this antiretroviral therapy, inform your doctor if you have liver disease, hepatitis B or C co-infection, kidney impairment, or any history of mental health conditions. If you are pregnant or planning to become pregnant, discuss the risks and benefits carefully with your physician — rare cases of neural tube defects have been reported with dolutegravir use during early pregnancy (around the time of conception), so appropriate contraception and timing of treatment initiation must be considered. This Tivicay generic may cause modest increases in blood sugar levels or elevations in liver enzymes (ALT/AST) in some patients, particularly those with pre-existing metabolic conditions. Regular monitoring of viral load, CD4 counts, liver function, kidney function, and metabolic parameters is strongly advised throughout treatment. Patients with hepatitis B co-infection should not abruptly stop dolutegravir, as this may trigger a severe hepatitis B flare. Immune reconstitution inflammatory syndrome (IRIS) may occur as the immune system recovers, potentially unmasking previously hidden opportunistic infections.

Contraindications

Dolutegravir is contraindicated in patients with confirmed hypersensitivity to the drug or any of its inactive components. It must not be used concurrently with dofetilide, as the interaction may lead to dangerously elevated dofetilide levels and life-threatening cardiac arrhythmias. Caution is strongly advised when prescribing this integrase inhibitor to individuals with severe hepatic impairment, as drug metabolism may be significantly altered. Women in the first trimester of pregnancy or those actively trying to conceive should discuss alternative antiretroviral options with their HIV specialist. Always consult your healthcare provider before combining dolutegravir with other medications or making changes to your AIDS medication regimen.

Possible side effect

Common side effects of dolutegravir include insomnia or difficulty sleeping, headache, nausea, diarrhea, and fatigue. Some patients may experience elevated liver enzymes, mild skin rash, or changes in body fat distribution (lipodystrophy), which can include increased fat in the upper back, trunk, or abdomen. Less common but clinically significant side effects include weight gain, increased cholesterol levels, and musculoskeletal complaints such as joint pain or muscle aches. Rare but serious adverse effects include severe allergic reactions (hypersensitivity syndrome with rash, fever, and organ involvement), significant liver toxicity (hepatotoxicity), and neuropsychiatric effects such as depression, anxiety, or suicidal thoughts — these require immediate medical evaluation. Report any unusual or persistent symptoms to your doctor promptly, as early intervention can prevent serious complications during HIV treatment.

Drug interaction

Dolutegravir interacts significantly with several commonly used medications and supplements. Antacids containing aluminum, magnesium, or calcium, as well as iron supplements and calcium-containing products, can substantially reduce dolutegravir absorption — these products should be taken at least 2 hours before or 6 hours after your INSTI dose. Dolutegravir also interacts with metformin (a common diabetes medication), potentially increasing metformin levels and requiring dose adjustment. Strong enzyme inducers such as rifampin, carbamazepine, and efavirenz may decrease dolutegravir blood levels, necessitating dose increases. Conversely, dolutegravir may increase levels of certain drugs processed through the OCT2 and MATE1 transport pathways. Always provide your healthcare provider with a complete list of all prescription medications, over-the-counter drugs, vitamins, and herbal supplements you use to ensure safe and effective antiretroviral therapy.

Missed dose

If you miss a dose of dolutegravir, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose — do not take a double dose to compensate. Consistent daily adherence to your HIV treatment regimen is essential to maintain viral suppression and prevent the emergence of drug-resistant virus. Even brief lapses in adherence can allow the virus to replicate and potentially develop resistance to your INSTI medication. Setting daily alarms, using pill organizers, or linking doses to a regular daily activity can help maintain consistent adherence to your antiretroviral therapy.

Overdose

Overdose with dolutegravir is rare but may cause exaggerated side effects such as increased nausea, fatigue, headache, or dizziness. There is no specific antidote for this integrase inhibitor, so treatment in overdose situations is supportive and symptomatic. Due to dolutegravir's high protein binding, hemodialysis is unlikely to be effective in removing the drug from the bloodstream. If an overdose is suspected, seek medical attention promptly and bring the medication packaging for identification.

Storage

Store dolutegravir tablets at room temperature (20°C to 25°C / 68°F to 77°F), in a dry place protected from heat, moisture, and direct sunlight. Keep the tablets in their original container with the desiccant packet to protect from humidity, and ensure the container is tightly closed after each use. Keep this Tivicay generic out of reach of children and pets. Do not use after the expiration date printed on the label. Always dispose of unused AIDS medication properly according to local pharmaceutical waste guidelines.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.